Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?

Hagikura M, Iwamoto K, Aleksic B, Ozaki N.

Psychiatry Clin Neurosci. 2012 Aug;66(5):463. doi: 10.1111/j.1440-1819.2012.02362.x. No abstract available.

PMID:
22834671
[PubMed - indexed for MEDLINE]
2.

Comments on 'what is a rational antidepressant treatment for major depression in patients with Parkinson's disease?'.

Pae CU.

Psychiatry Clin Neurosci. 2013 Jan;67(1):65-6. doi: 10.1111/pcn.12009. No abstract available.

PMID:
23331292
[PubMed - indexed for MEDLINE]
3.

Mirtazapine for depression in patients with human immunodeficiency virus.

Elliott AJ, Roy-Byrne PP.

J Clin Psychopharmacol. 2000 Apr;20(2):265-7. No abstract available.

PMID:
10770469
[PubMed - indexed for MEDLINE]
4.

[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].

Ladeira RB, Cunha FT, Salgado JV, Teixeira AL, Nicolato R.

Rev Bras Psiquiatr. 2008 Sep;30(3):299-300. Portuguese. No abstract available.

PMID:
18833439
[PubMed - indexed for MEDLINE]
Free Article
5.

Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.

Moustgaard G.

J Clin Psychopharmacol. 2000 Apr;20(2):268. No abstract available.

PMID:
10770470
[PubMed - indexed for MEDLINE]
6.

Functional dyspepsia and mirtazapine.

Lee SY, Rho SH, Choi SC.

Can J Psychiatry. 2002 Aug;47(6):582-3. No abstract available.

PMID:
12211889
[PubMed - indexed for MEDLINE]
7.

Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.

Lecei O, Lederbogen F, Gronau W, Scharnholz B, Terhardt J, Schilling C, Gilles M, Kopf D, Roth HJ, Weber-Hamann B, Deuschle M.

J Clin Psychopharmacol. 2012 Aug;32(4):574-6. doi: 10.1097/JCP.0b013e31825ddf1b. No abstract available.

PMID:
22760352
[PubMed - indexed for MEDLINE]
8.

Comments on "Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder".

Pae CU.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):597-8. Epub 2007 Sep 11. No abstract available.

PMID:
17919799
[PubMed - indexed for MEDLINE]
9.

Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.

Shen J, Moller HJ, Wang X, Chung SA, Shapiro GK, Li X, Shapiro CM.

J Clin Psychiatry. 2009 Mar;70(3):370-7. Epub 2009 Jan 13.

PMID:
19192466
[PubMed - indexed for MEDLINE]
10.

Flunarizine- and topiramate-associated depression responsive to mirtazapine.

Bourgeois JA, Hategan A.

Psychosomatics. 2013 Sep-Oct;54(5):503-4. doi: 10.1016/j.psym.2013.01.013. No abstract available.

PMID:
24034532
[PubMed - indexed for MEDLINE]
11.

Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?

Pae CU, Kim TS, Kim JJ, Chae JH, Lee CU, Lee SJ, Paik IH, Lee C.

Psychiatry Clin Neurosci. 2004 Dec;58(6):669-70. No abstract available.

PMID:
15601394
[PubMed - indexed for MEDLINE]
12.

Mirtazapine: a review of its use in major depression and other psychiatric disorders.

Croom KF, Perry CM, Plosker GL.

CNS Drugs. 2009;23(5):427-52. doi: 10.2165/00023210-200923050-00006. Review.

PMID:
19453203
[PubMed - indexed for MEDLINE]
13.

Antidepressant switching among adherent patients treated for depression.

Marcus SC, Hassan M, Olfson M.

Psychiatr Serv. 2009 May;60(5):617-23. doi: 10.1176/appi.ps.60.5.617.

PMID:
19411348
[PubMed - indexed for MEDLINE]
14.

Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report.

Safer DL, Darcy AM, Lock J.

Int J Eat Disord. 2011 Mar;44(2):178-81. doi: 10.1002/eat.20793.

PMID:
20127940
[PubMed - indexed for MEDLINE]
15.

Acute reversible dyskinesia induced by mirtazapine.

Konitsiotis S, Pappa S, Mantas C, Mavreas V.

Mov Disord. 2005 Jun;20(6):771. No abstract available.

PMID:
15732128
[PubMed - indexed for MEDLINE]
16.

Mirtazapine-induced manic switch in adolescent unipolar depression.

Goyal N, Sinha VK.

Aust N Z J Psychiatry. 2008 Dec;42(12):1070-1. No abstract available.

PMID:
19031640
[PubMed - indexed for MEDLINE]
17.

Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.

Al-Adwani A.

Can J Psychiatry. 2005 Nov;50(13):877; author reply 877-8. No abstract available.

PMID:
16483124
[PubMed - indexed for MEDLINE]
18.

Disability and borderline personality symptoms.

Sansone RA, Hruschka J, Vasudevan A, Miller SN.

Psychosomatics. 2003 Sep-Oct;44(5):442. No abstract available.

PMID:
12954928
[PubMed - indexed for MEDLINE]
19.

[Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].

Schmidt FM, Tennert C, Teupser D, Himmerich H.

Psychiatr Prax. 2012 Jul;39(5):239-42. doi: 10.1055/s-0032-1305013. Epub 2012 Jun 11. German.

PMID:
22689282
[PubMed - indexed for MEDLINE]
20.

Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.

Deuschle M, Angermeier T, Westphal S, Lederbogen F, Gilles M, Frankhauser P, Schilling C, Onken V, Weber-Hamann B, Kopf D.

Psychother Psychosom. 2010;79(2):123-5. doi: 10.1159/000276374. Epub 2009 Feb 27. No abstract available.

PMID:
20090399
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk